| Camptothecin | IC50 | 3750.0 [1] |
| Topotecan | IC50 | 1100.0 [1] |
| Doxorubicin | IC50 | 20000.0 [1], 200000.0 [2] |
| 3-[(E)-4-Hydroxybenzylidene]-6-hydroxybenzofuran-2(3H)-one | IC50 | 307000.0 [1], 400000.0 [2] |
| 9-Aminocamptothecin | IC50 | 110.0 [1], 1800.0 [2], 4200.0 [3] |
| 10,11-Methylenedioxy-20S-camptothecin | IC50 | 27.0 [1], 30.0 [2], 78.0 [3] |
| Topostatin | IC50 | 29000.0 [1], 50000.0 [2], 55000.0 [3] |
| Chebulagic acid | IC50 | 50.0 [1], 100.0 [2] |
| 10,11-Methylenedioxy-20(RS)-camptothecin | IC50 | 38.0 [1], 67.0 [2] |
| 9-Amino-20-camptothecin | IC50 | 440.0 [1], 840.0 [2] |
| (+)-Camptothecin | IC50 | 1400.0 [1], 1600.0 [2] |
| (19S)-7-Bromo-19-ethyl-19-hydroxy-10-methyl-17-oxa-3,6,13-triazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | IC50 | 28.0 [1] |
| (19S)-19-Ethyl-19-hydroxy-10-methyl-14,18-dioxo-17-oxa-3,6,13-triazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-7-carbonitrile | IC50 | 143.0 [1] |
| 6,20-Dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-3,13,23-triazahexacyclo[14.7.0.02,10.04,9.011,15.017,22]tricosa-1,4(9),5,7,10,15,17(22),18,20-nonaene-12,14-dione | IC50 | 30.0 [1], 2300.0 [2] |
| 4-(Furan-2-yl)-2-[(E)-2-(furan-2-yl)ethenyl]-6-thiophen-2-ylpyridine | IC50 | 10000.0 [1], 200000.0 [2] |
| Aesculioside IV-23D1 | IC50 | 23800.0 [1], 27100.0 [2] |
| AesculiosideIV-23C1 | IC50 | 23800.0 [1], 53000.0 [2] |
| Aesculioside IV-23E | IC50 | 23800.0 [1], 32700.0 [2] |
| 2,4,6-Tris(furan-2-yl)pyridine | IC50 | 500000.0 [1], 1000000.0 [2] |
| (5-Ethyl-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(13),2,4(9),14,16,21,23-heptaen-5-yl) 2-aminoacetate;hydrochloride | IC50 | 430.0 [1], 2500.0 [2] |
| (8-Amino-19-ethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaen-19-yl) 2-aminoacetate;hydrochloride | IC50 | 5500.0 [1], 6800.0 [2] |
| 2-Amino-N-(5-ethyl-5-hydroxy-6,10-dioxo-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaen-16-yl)acetamide;hydrochloride | IC50 | 260.0 [1], 30000.0 [2] |
| Aesculioside IVa | IC50 | 23800.0 [1], 51800.0 [2] |
| Aesculioside IVc | IC50 | 23800.0 [1], 49700.0 [2] |
| Aesculioside IVb | IC50 | 23800.0 [1], 36000.0 [2] |
| Aesculioside IIIb | IC50 | 23800.0 [1], 160000.0 [2] |
| Aesculioside IIIa | IC50 | 23800.0 [1], 118700.0 [2] |
| Aesculioside IIc | IC50 | 23800.0 [1], 110500.0 [2] |
| Aesculioside IId | IC50 | 23800.0 [1] |
| 3,4,5-Trihydroxy-N-[2-[(3,4,5-trihydroxybenzoyl)amino]phenyl]benzamide | IC50 | 900.0 [1] |
| 3,4,5-Trihydroxy-N-[2-[(3,4,5-trihydroxybenzoyl)amino]phenyl]benzamide | Ki | 400.0 [1] |
| 16-Amino-5-ethyl-5-hydroxy-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaene-6,10-dione | IC50 | 69.0 [1], 76.0 [2] |
| 2-Amino-N-(19-ethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-8-yl)acetamide | IC50 | 570.0 [1], 30000.0 [2] |
| Etoposide | IC50 | 1000000.0 [1] |
| Reserpine | IC50 | 160000.0 [1] |
| Ribavirin | IC50 | 65880.0 [1] |
| Oleic acid | IC50 | 31000.0 [1] |
| 7-Ethyl-10-hydroxycamptothecin | IC50 | 5500.0 [1] |
| Pibenzimol | IC50 | 22860.0 [1] |
| Hoechst 33342 | IC50 | 50000.0 [1] |
| Netropsin | IC50 | 62000.0 [1] |
| 10-Hydroxycamptothecin | IC50 | 110.0 [1] |
| Shikonin | IC50 | 208000.0 [1] |
| Ginsenoside rb1 | IC50 | 250000.0 [1] |
| Stallimycin | IC50 | 2700.0 [1] |
| Ginsenoside Rg3 | IC50 | 250000.0 [1] |
| Corilagin | IC50 | 40000.0 [1] |
| Elaidic acid | IC50 | 1000000.0 [1] |
| Ginsenoside Re | IC50 | 250000.0 [1] |
| Gypenoside VIII | IC50 | 250000.0 [1] |
| alpha-Amyrin | IC50 | 250000.0 [1] |
| Unii-ST04094S3X | IC50 | 45000.0 [1] |
| Simocyclinone D8 | IC50 | 60000.0 [1] |
| Ginsenoside F2 | IC50 | 250000.0 [1] |
| beta,beta-Dimethylacrylshikonin | IC50 | 77000.0 [1] |
| 20R-Camptothecin | IC50 | 30000.0 [1] |
| 3-[[4-[Bis(4-hydroxy-2-oxochromen-3-yl)methyl]phenyl]-(4-hydroxy-2-oxochromen-3-yl)methyl]-4-hydroxychromen-2-one | IC50 | 10000.0 [1] |
| Ganoderiol F | IC50 | 106000.0 [1] |
| (5R)-5-Ethyl-5-hydroxy-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(13),2,4(9),14,16,21,23-heptaene-6,10-dione | IC50 | 30000.0 [1] |
| (20R)-Ginsenoside Rg3 | IC50 | 250000.0 [1] |
| Unii-W6V49A8fjq | IC50 | 250000.0 [1] |
| 5,7-Dioxa-12-azoniapentacyclo[10.6.1.02,10.04,8.015,19]nonadeca-1(18),2,4(8),9,11,15(19),16-heptaen-17-olate | IC50 | 6100.0 [1] |
| Acetic acid 4-[2-(4-acetoxy-benzoylamino)-phenylcarbamoyl]-phenyl ester | IC50 | 100000.0 [1] |
| Gallanilide | IC50 | 100000.0 [1] |
| 6H-Purin-6-one, 2-((3,4-dichlorophenyl)amino)-1,9-dihydro- | IC50 | 200000.0 [1] |
| Sodium camptothecin | IC50 | 12000.0 [1] |
| Gypenoside XVII | IC50 | 250000.0 [1] |
| (11E)-9-Methoxy-11-(2-pyrrolidin-1-ylethoxyimino)-5H-indeno[1,2-c]quinolin-6-one | IC50 | 3760.0 [1] |
| 3-[[4-[Bis(1-hydroxy-3,4-dioxonaphthalen-2-yl)methyl]phenyl]-(1-hydroxy-3,4-dioxonaphthalen-2-yl)methyl]-4-hydroxynaphthalene-1,2-dione | IC50 | 60000.0 [1] |
| (5S)-14-(Chloromethyl)-5-ethyl-5-hydroxy-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaene-6,10-dione | IC50 | 15.0 [1] |
| (10S)-10-Ethyl-10-hydroxy-23-pentyl-8-oxa-4,15,21,23-tetrazahexacyclo[14.7.1.02,14.04,13.06,11.020,24]tetracosa-1,6(11),12,14,16(24),17,19,21-octaene-5,9-dione | IC50 | 2300.0 [1] |
| Butylshikonin | IC50 | 144000.0 [1] |
| 9-Hydroxycamptothecine | IC50 | 870.0 [1] |
| [(1R)-1-(1,4-Dihydroxy-5,8-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] 2-methylpropanoate | IC50 | 84000.0 [1] |
| Kaempferol 3-O-beta-D-glucopyranosyl-7-O-alpha-L-rhamnopyranoside | IC50 | 110000.0 [1] |
| 2,4-Pyrimidinediamine, 6-chloro-N4-(3,4-dichlorophenyl)- | IC50 | 200000.0 [1] |
| Ginsenoside F3 | IC50 | 250000.0 [1] |
| N~2~-(3,4-Dichlorophenyl)-9H-purine-2,6-diamine | IC50 | 200000.0 [1] |
| 6-(4-Methylpiperazin-1-yl)-2-[2-(4-prop-2-ynoxyphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole | IC50 | 25410.0 [1] |
| 10-Aminocamptothecin | IC50 | 140.0 [1] |
| 2-(4-Hex-5-ynoxyphenyl)-6-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-benzimidazole | IC50 | 50000.0 [1] |
| 6-(4-Methylpiperazin-1-yl)-2-[2-[4-(4-prop-2-ynoxybutoxy)phenyl]-3H-benzimidazol-5-yl]-1H-benzimidazole | IC50 | 50000.0 [1] |
| 6-(4-Methylpiperazin-1-yl)-2-[2-(4-undec-10-ynoxyphenyl)-3H-benzimidazol-5-yl]-1H-benzimidazole | IC50 | 50000.0 [1] |
| Propionylshikonin | IC50 | 44000.0 [1] |
| N-(2-Benzamidophenyl)benzamide | IC50 | 100000.0 [1] |
| 9-Methoxy-6-(piperazin-1-yl)-11H-indeno[1,2-c]quinolin-11-one O-3-(dimethylamino)propyl oxime | IC50 | 6600.0 [1] |
| 9-Methoxy-11H-indeno[1,2-c]quinolin-11-one | IC50 | 100000.0 [1] |
| (2R,3S,4S,5R,6S)-2-[[(2S,3S,4S,5R)-3,4-Dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol | IC50 | 250000.0 [1] |
| (5S)-16-Amino-5-ethyl-5-hydroxy-7,18,20-trioxa-11,24-diazahexacyclo[11.11.0.02,11.04,9.015,23.017,21]tetracosa-1(24),2,4(9),13,15,17(21),22-heptaene-6,10-dione | IC50 | 48.0 [1] |
| (E,6R)-6-[(3S,5R,10S,13R,14R,15S,17R)-15-Acetyloxy-3-hydroxy-4,4,10,13,14-pentamethyl-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylhept-2-enoic acid | IC50 | 55000.0 [1] |
| (19S)-19-Ethyl-19-hydroxy-8-methyl-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione | IC50 | 38.0 [1] |
| (18S)-2-(Chloromethyl)-18-ethyl-18-hydroxy-6,9,20-trioxa-13,24-diazahexacyclo[12.11.0.03,12.05,10.015,24.017,22]pentacosa-1,3,5(10),11,13,15,17(22)-heptaene-19,23-dione | IC50 | 11.0 [1] |
| [(1R)-1-(5,8-Dihydroxy-1,4-dioxonaphthalen-2-yl)-4-methylpent-3-enyl] pentanoate | IC50 | 161000.0 [1] |
| 2-[(R)-1-(Benzoyloxy)-4-methyl-3-pentenyl]-5,8-dihydroxy-1,4-naphthoquinone | IC50 | 153000.0 [1] |
| (19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,6,13-triazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-7-carboximidamide | IC50 | 33.0 [1] |
| (3E)-3-[(3-Hydroxy-4-methoxyphenyl)methylidene]-1-benzofuran-2-one | IC50 | 800000.0 [1] |
| (19S)-7-(Aminomethyl)-19-ethyl-19-hydroxy-10-methyl-17-oxa-3,6,13-triazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione | IC50 | 232.0 [1] |
| 20(S)-Ginsenoside Rg2 | IC50 | 250000.0 [1] |
| 6-(4-Methylpiperazin-1-yl)-2-[2-[4-(8-prop-2-ynoxyoctoxy)phenyl]-3H-benzimidazol-5-yl]-1H-benzimidazole | IC50 | 50000.0 [1] |
| 6-(4-Methylpiperazin-1-yl)-2-[2-[4-(12-prop-2-ynoxydodecoxy)phenyl]-3H-benzimidazol-5-yl]-1H-benzimidazole | IC50 | 50000.0 [1] |